Organic Solvents as Vehicles for Precipitating Liquid Embolics: A Comparative Angiotoxicity Study with Superselective Injections of Swine Rete Mirabile

References

1. ↵
   Yang X, Wu Z, Li Y, et al. Re-evaluation of cellulose acetate polymer: angiographic findings and histological studies. Surg Neurol 2001;55:116–22

   CrossRefPubMed
2. Mandai S, Kinugasa K, Ohmoto T. Direct thrombosis of aneurysms with cellulose acetate polymer. Part I: Results of thrombosis in experimental aneurysms. J Neurosurg 1992;77:497–500

   PubMed
3. Taki W, Yonekawa Y, Iwata H, et al. A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol 1990;11:163–68

   Abstract/FREE Full Text
4. Hamada J, Kai Y, Morioka M, et al. A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolic agent to treat cerebral arteriovenous malformations: initial clinical experience. J Neurosurg 2002;97:881–88

   PubMed
5. ↵
   Murayama Y, Vinuela F, Ulhoa A, et al. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 1998;43:1164–75

   CrossRefPubMedWeb of Science
6. ↵
   Murayama Y, Vinuela F, Tateshima S, et al. Endovascular treatment of experimental aneurysms by use of a combination of liquid embolic agents and protective devices. AJNR Am J Neuroradiol 2000;21:1726–35

   Abstract/FREE Full Text
7. ↵
   Jahan R, Murayama Y, Gobin YP, et al. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 2001;48:984–95

   CrossRefPubMedWeb of Science
8. Mawad ME, Cekirge S, Ciceri E, et al. Endovascular treatment of giant and large intracranial aneurysms by using a combination of stent placement and liquid polymer injection. J Neurosurg 2002;96:474–82

   PubMedWeb of Science
9. Molyneux AJ, Cekirge S, Saatci I, et al. Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers. AJNR Am J Neuroradiol 2004;25:39–51

   Abstract/FREE Full Text
10. Nishi S, Taki W, Nakahara I, et al. Embolization of cerebral aneurysms with a liquid embolus, EVAL mixture: report of three cases. Acta Neurochir (Wien) 1996;138:294–300

    PubMed
11. ↵
    Saatci I, Cekirge HS, Ciceri EF, et al. CT and MR imaging findings and their implications in the follow-up of patients with intracranial aneurysms treated with endosaccular occlusion with onyx. AJNR Am J Neuroradiol 2003;24:567–78

    Abstract/FREE Full Text
12. ↵
    Davis JM, Rowley SD, Braine HG, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75:781–86

    Abstract/FREE Full Text
13. ↵
    Samoszuk M, Reid ME, Toy PT. Intravenous dimethylsulfoxide therapy causes severe hemolysis mimicking a hemolytic transfusion reaction. Transfusion 1983;23:405

    PubMedWeb of Science
14. Stroncek DF, Fautsch SK, Lasky LC, et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:521–26

    CrossRefPubMedWeb of Science
15. Smith DM, Weisenburger DD, Bierman P, et al. Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transplant 1987;2:195–201

    PubMed
16. Hameroff SR, Otto CW, Kanel J, et al. Acute cardiovascular effects of dimethyl sulfoxide. Ann N Y Acad Sci 1983;411:94–99

    CrossRefPubMed
17. Rapoport AP, Rowe JM, Packman CH, et al. Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant 1991;7:401–03

    PubMed
18. ↵
    Styler MJ, Topolsky DL, Crilley PA, et al. Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 1992;10:435–38

    PubMed
19. Baum CM, Weissman IL, Tsukamoto AS, et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A 1992;89:2804–08

    Abstract/FREE Full Text
20. ↵
    Burgess JL, Hamner AP, Robertson WO. Sulfhemoglobinemia after dermal application of DMSO. Vet Hum Toxicol 1998;40:87–89

    PubMed
21. ↵
    Topacoglu H, Karcioglu O, Ozsarac M, et al. Massive intracranial hemorrhage associated with the ingestion of dimethyl sulfoxide. Vet Hum Toxicol 2004;46:138–40

    PubMed
22. ↵
    Chaloupka JC, Vinuela F, Vinters HV, et al. Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model. AJNR Am J Neuroradiol 1994;15:1107–15

    Abstract/FREE Full Text
23. Laurent A, Wassef M, Zhang HQ, et al. Solutions gélifiantes pour embolisation: etude animale de la toxicité cardiovasculaire d’un constituant, le diméthylsulfoxyde. J Neuroradiol 1997;24:314
24. Sampei K, Hashimoto N, Kazekawa K, et al. Histological changes in brain tissue and vasculature after intracarotid infusion of organic solvents in rats. Neuroradiology 1996;38:291–94

    PubMedWeb of Science
25. Hamada J, Kai Y, Morioka M, et al. A nonadhesive liquid embolic agent composed of ethylene vinyl alcohol copolymer and ethanol mixture for the treatment of cerebral arteriovenous malformations: experimental study. J Neurosurg 2002;97:889–95

    PubMed
26. ↵
    Laurent A, Dufaux J, Honiger J, et al. Injectable gel-giving solutions for embolization: hydrodynamic and animal studies. Proceedings of the Société Française de Neuroradiologie (SFNR) 1997;25:46
27. ↵
    Chaloupka JC, Huddle DC, Alderman J, et al. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol 1999;20:401–10

    Abstract/FREE Full Text
28. ↵
    Mottu F, Laurent A, Rufenacht DA, et al. Organic solvents for pharmaceutical parenterals and embolic liquids: a review of toxicity data. PDA J Pharm Sci Technol 2000;54:456–69

    Abstract/FREE Full Text
29. ↵
    Mottu F, Gailloud P, Massuelle D, et al. In vitro assessment of new embolic liquids prepared from preformed polymers and water-miscible solvents for aneurysm treatment. Biomaterials 2000;21:803–11

    PubMed
30. ↵
    Powell MF, Nguyen T, Baloian L. Compendium of excipients for parenteral formulations. PDA J Pharm Sci Technol 1998;52:238–311

    FREE Full Text
31. ↵
    Heintz C, Boymond C. Aspects pharmaco-toxicologiques et utilisation thérapeutique de quelques solvants injectables non aqueux miscibles à l’eau. STP Pharma 1989;5:548–60
32. ↵
    Mottu F, Stelling MJ, Rufenacht DA, et al. Comparative hemolytic activity of undiluted organic water-miscible solvents for intravenous and intra-arterial injection. PDA J Pharm Sci Technol 2001;55:16–23

    Abstract/FREE Full Text
33. ↵
    National Industrial Chemicals Notification and Assessment Scheme. Canberra, Australia, 2004. Full report on Arlasolve DMI. Available at: http://www.nicnas.gov.au/publications/CAR/new/Std/stdFULLR/std1000FR/std1052FR.pdf. Accessed2004 Oct 17
34. ↵
    Simonsen L, Petersen MB, Groth L. In vivo skin penetration of salicylic compounds in hairless rats. Eur J Pharm Sci 2002;17:95–104

    PubMed
35. ↵
    Squillante E, Needham T, Maniar A, et al. Codiffusion of propylene glycol and dimethyl isosorbide in hairless mouse skin. Eur J Pharm Biopharm 1998;46:265–71

    CrossRefPubMed
36. ↵
    Arlasolve (Dimethyl isosorbide). ICI Technical Note,1995
37. ↵
    Hodosh M, Hodosh SH, Hodosh AJ. Treatment of aphthous stomatitis with saturated potassium nitrate/dimethyl isosorbide. Quintessence Int 2004;35:137–41

    PubMed
38. ↵
    Hazardous Substances Data Bank. Bethesda, MD: National Library of Medicine (US), 2004. Dimethyl isosorbide. Available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed2004 Oct 17
39. ↵
    Report on carcinogens, 10th ed. Triangle Park, NC: US Department of Health and Human Services, Public Health Service, National Toxicology Program;2002
40. ↵
    Hazardous Substances Data Bank. Bethesda, MD: National Library of Medicine (US), 2004. 1-Methyl-2-pyrollidone. Available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed2004 Oct 17
41. ↵
    Priborsky J, Muhlbachova E. Evaluation of in-vitro percutaneous absorption across human skin and in animal models. J Pharm Pharmacol 1990;42:468–72

    PubMed
42. Koizumi A, Fujii M, Kondoh M, et al. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biopharm 2004;57:473–78

    PubMed
43. ↵
    Payan JP, Boudry I, Beydon D, et al. Toxicokinetics and metabolism of N-[¹⁴C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: in vivo and in vitro percutaneous absorption. Drug Metab Dispos 2003;31:659–69

    Abstract/FREE Full Text
44. ↵
    Akesson B, Paulsson K. Experimental exposure of male volunteers to N-methyl-2-pyrrolidone (NMP): acute effects and pharmacokinetics of NMP in plasma and urine. Occup Environ Med 1997;54:236–40

    Abstract/FREE Full Text
45. ↵
    Akesson B, Jonsson BA. Major metabolic pathway for N-methyl-2-pyrrolidone in humans. Drug Metab Dispos 1997;25:267–69

    Abstract/FREE Full Text
46. ↵
    Pharmasolve (N-methyl-2-pyrrolidone). ISP Technical Note,1990
47. ↵
    Wells DA, Thomas HF, Digenis GA. Mutagenicity and cytotoxicity of N-methyl-2-pyrrolidinone and 4-(methylamino)butanoic acid in the Salmonella/microsome assay. J Appl Toxicol 1988;8:135–39

    PubMed
48. ↵
    Engelhardt G, Fleig H. 1-Methyl-2-pyrrolidinone (NMP) does not induce structural and numerical chromosomal aberrations in vivo. Mutat Res 1993;298:149–55

    PubMed
49. ↵
    Zimmermann FK, Holzwarth UL, Scheel I, et al. Aprotic polar solvents that affect porcine brain tubulin aggregation in vitro induce aneuploidy in yeast cells growing at low temperatures. Mutat Res 1988;201:431–42

    CrossRefPubMed
50. ↵
    Mayer VW, Goin CJ, Taylor-Mayer RE. Aneuploidy induction in saccharomyces cerevisiae by two solvent compounds, 1-methyl-2-pyrrolidinone and 2-pyrrolidinone. Environ Mol Mutagen 1988;11:31–40

    PubMed
51. ↵
    Lee KP, Chromey NC, Culik R, et al. Toxicity of N-methyl-2-pyrrolidone (NMP): teratogenic, subchronic, and two-year inhalation studies. Fundam Appl Toxicol 1987;9:222–35

    CrossRefPubMedWeb of Science
52. ↵
    Saillenfait AM, Gallissot F, Langonne I, et al. Developmental toxicity of N-methyl-2-pyrrolidone administered orally to rats. Food Chem Toxicol 2002;40:1705–12

    CrossRefPubMedWeb of Science
53. ↵
    Saillenfait AM, Gallissot F, Morel G. Developmental toxicity of N-methyl-2-pyrrolidone in rats following inhalation exposure. Food Chem Toxicol 2003;41:583–88

    CrossRefPubMedWeb of Science
54. ↵
    Reed KW, Yalkowsky SH. Lysis of human red blood cells in the presence of various cosolvents. J Parenteral Sci Technol 1985;39:64–68